Beauty Health Price to Sales Ratio 2020-2024 | SKIN
Historical PS ratio values for Beauty Health (SKIN) over the last 10 years. The current P/S ratio for Beauty Health as of December 02, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Beauty Health P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2024-11-29 | 1.48 | 0.58 | |
| 2024-09-30 | 1.44 | $2.57 | 0.56 |
| 2024-06-30 | 1.92 | $2.67 | 0.72 |
| 2024-03-31 | 4.44 | $2.92 | 1.52 |
| 2023-12-31 | 3.11 | $3.01 | 1.03 |
| 2023-09-30 | 6.02 | $2.93 | 2.05 |
| 2023-06-30 | 8.37 | $2.78 | 3.01 |
| 2023-03-31 | 12.63 | $2.58 | 4.89 |
| 2022-12-31 | 9.10 | $2.42 | 3.75 |
| 2022-09-30 | 11.79 | $2.53 | 4.67 |
| 2022-06-30 | 12.86 | $2.45 | 5.24 |
| 2022-03-31 | 16.88 | $2.50 | 6.76 |
| 2021-12-31 | 24.16 | $3.34 | 7.23 |
| 2021-09-30 | 25.97 | $2.58 | 10.07 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.184B | $0.398B |
| The Beauty Health Company is a beauty health company. Its flagship brand HydraFacial is a non-invasive and approachable beauty health platform and ecosystem with a powerful community of estheticians, consumers and partners, bridging medical and consumer retail to democratize and personalize skin care solutions for the masses. The Beauty Health Company, formerly known as Vesper Healthcare Acquisition Corp., is based in CHICAGO, Utah. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $94.383B | 11.71 |
| Cencora (COR) | United States | $49.567B | 18.28 |
| DiDi Global (DIDIY) | China | $22.941B | 0.00 |
| Natera (NTRA) | United States | $22.150B | 0.00 |
| ICON (ICLR) | Ireland | $17.345B | 15.45 |
| Viatris (VTRS) | United States | $15.624B | 4.81 |
| Avantor (AVTR) | United States | $14.334B | 21.49 |
| Revvity (RVTY) | United States | $14.134B | 24.55 |
| CochLear (CHEOY) | Australia | $13.051B | 0.00 |
| Solventum (SOLV) | United States | $12.354B | 0.00 |
| BioMerieux (BMXMF) | France | $12.257B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.587B | 29.83 |
| Charles River Laboratories (CRL) | United States | $10.179B | 19.67 |
| Doximity (DOCS) | United States | $9.895B | 58.24 |
| HealthEquity (HQY) | United States | $8.867B | 48.12 |
| Sonic Healthcare (SKHHY) | Australia | $8.862B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.980B | 32.49 |
| Life Times (LTH) | United States | $5.023B | 33.25 |
| Organon (OGN) | United States | $4.087B | 4.12 |
| Sotera Health (SHC) | United States | $3.730B | 19.95 |
| BrightSpring Health Services (BTSG) | United States | $3.361B | 71.48 |
| Surgery Partners (SGRY) | United States | $3.030B | 34.55 |
| Concentras Parent (CON) | United States | $2.779B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.417B | 0.00 |
| PACS (PACS) | United States | $2.409B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.281B | 0.00 |
| Premier (PINC) | United States | $2.201B | 11.45 |
| GeneDx Holdings (WGS) | United States | $2.153B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.063B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.995B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.845B | 48.40 |
| Progyny (PGNY) | United States | $1.326B | 26.84 |
| CareDx (CDNA) | United States | $1.316B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.285B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.285B | 12.57 |
| Embecta (EMBC) | United States | $1.202B | 8.47 |
| AMN Healthcare Services Inc (AMN) | United States | $0.991B | 6.71 |
| Agilon Health (AGL) | United States | $0.861B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 0.00 |
| SBC Medicals (SBC) | United States | $0.745B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.660B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.531B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.497B | 0.00 |
| DocGo (DCGO) | United States | $0.442B | 16.65 |
| Enhabit (EHAB) | United States | $0.389B | 33.61 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.314B | 0.00 |
| LifeMD (LFMD) | United States | $0.285B | 0.00 |
| ModivCare (MODV) | United States | $0.268B | 14.57 |
| Sera Prognostics (SERA) | United States | $0.228B | 0.00 |
| Biodesix (BDSX) | United States | $0.209B | 0.00 |
| Nutex Health (NUTX) | United States | $0.202B | 0.00 |
| MultiPlan (MPLN) | United States | $0.128B | 0.00 |
| So-Young (SY) | China | $0.098B | 16.60 |
| Ascend Wellness Holdings (AAWH) | United States | $0.086B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.055B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 1.11 |
| OncoCyte (OCX) | United States | $0.041B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.038B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.030B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.028B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.019B | 0.00 |
| Oncology Institute (TOI) | United States | $0.012B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.011B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| KindlyMD (KDLY) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |